David R. Sell

8.4k citations

81 papers · 6.4k indexed · 1 hit paper · h-index 40

Clinical Biochemistry top 0.02%
Endocrinology, Diabetes and Metabolism top 0.5%
Molecular Biology top 5%
Physiology top 2%
Pathology and Forensic Medicine top 2%

Co-authors: Vincent M. Monnier Saul Genuth Patrizio Odetti Patricia A. Cleary John Fogarty Christopher Strauch William T. Dahms Ramanakoppa H. Nagaraj
Topics: Advanced Glycation End Products research (56 papers)Biochemical effects in animals (11 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers)
Cited by: Clinical Biochemistry Endocrinology, Diabetes and Metabolism Aging
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States United Kingdom Norway

In The Last Decade

David R. Sell

81 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix

1989 901 citations David R. Sell, Vincent M. Monnier Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by David R. Sell

Since Specialization

Citations

This map shows the geographic impact of David R. Sell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Sell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Sell more than expected).

Fields of papers citing papers by David R. Sell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Sell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Sell. The network helps show where David R. Sell may publish in the future.

Co-authorship network of co-authors of David R. Sell

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Sell. A scholar is included among the top collaborators of David R. Sell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Sell. David R. Sell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	α-Crystallin chaperone mimetic drugs inhibit lens γ-crystallin aggregation: Potential role for cataract prevention 2022 ·Journal of Biological Chemistry ·Sidra Islam,(unknown),(unknown),Grant L. Hom,Samuel Wheeler,Hisashi Fujioka,Benlian Wang,(unknown),David R. Sell,Xingjun Fan,Kirsten J. Lampi,Vincent M. Monnier	8
2	Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes 2016 ·Cardiovascular Diabetology ·David R. Sell,Wanjie Sun,Xiaoyu Gao,Christopher Strauch,John M. Lachin,Patricia A. Cleary,Saul Genuth,Vincent M. Monnier	21
3	Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes 2015 ·Cardiovascular Diabetology ·Vincent M. Monnier,Wanjie Sun,Xiaoyu Gao,David R. Sell,Patricia A. Cleary,John M. Lachin,Saul Genuth	51
4	Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown),Harry R. Gosker,Chiel C. de Theije,(unknown),David R. Sell,Vincent M. Monnier,Niki L. Reynaert	16
5	Advanced Glycation End-Products Reduce Collagen Molecular Sliding to Affect Collagen Fibril Damage Mechanisms but Not Stiffness 2014 ·PLoS ONE ·Gion Fessel,Yufei Li,(unknown),Manuel Guizar‐Sicairos,Philipp Schneider,David R. Sell,Vincent M. Monnier,Jess G. Snedeker	113
6	Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications 2013 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Vincent M. Monnier,Wanjie Sun,David R. Sell,Xingjun Fan,Ina Nemet,Saul Genuth	57
7	Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia 2013 ·Bone ·Subhash C. Juneja,Alin Vonica,Caroline J. Zeiss,Kimberly Lezon-Geyda,Bogdan Yatsula,David R. Sell,Vincent M. Monnier,Sharon Lin,Thomas Ardito,David R. Eyre,David G. Reynolds,Zhenqiang Yao,Hani A. Awad,Hongbo Yu,Michael P. Wilson,Sylvie Honnons,Brendan F. Boyce,Lianping Xing,Yi Zhang,Archibald S. Perkins	17
8	Prevention and Repair of Protein Damage by the Maillard Reaction In Vivo 2006 ·Rejuvenation Research ·Vincent M. Monnier,David R. Sell	51
9	Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix 2005 ·Journal of Biological Chemistry ·David R. Sell,Klaus M. Biemel,Oliver Reihl,Markus O. Lederer,Christopher Strauch,Vincent M. Monnier	170
10	Conversion of Arginine into Ornithine by Advanced Glycation in Senescent Human Collagen and Lens Crystallins 2004 ·Journal of Biological Chemistry ·David R. Sell,Vincent M. Monnier	52
11	The Effect of Caloric Restriction on Glycation and Glycoxidation in Skin Collagen of Nonhuman Primates 2003 ·The Journals of Gerontology Series A ·David R. Sell,Mark A. Lane,Mark E. Obrenovich,Julie A. Mattison,April M. Handy,Donald K. Ingram,Richard G. Cutler,George S. Roth,Vincent M. Monnier	42
12	Effect of Chronic Aminoguanidine Treatment on Age-Related Glycation, Glycoxidation, and Collagen Cross-linking in the Fischer 344 Rat 2001 ·The Journals of Gerontology Series A ·David R. Sell,James F. Nelson,Vincent M. Monnier	41
13	A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden 2000 ·The Science of The Total Environment ·Adrian Frank,David R. Sell,Rolf Danielsson,John Fogarty,Vincent M. Monnier	19
14	Ageing promotes the increase of early glycation Amadori product as assessed by ϵ-N-(2-furoylmethyl)-l-lysine (furosine) levels in rodent skin collagen 1997 ·Mechanisms of Ageing and Development ·David R. Sell	32
15	Structure of advanced Maillard reaction products and their pathological role 1996 ·Nephrology Dialysis Transplantation ·Vincent M. Monnier,Ram H. Nagaraj,Manuel Portero-Otı́n,Marcus A. Glomb,(unknown),David R. Sell,Miriam A. Friedlander	64
16	Mechanisms of Protection against Damage Mediated by the Maillard Reaction in Aging 1991 ·Gerontology ·Vincent M. Monnier,David R. Sell,Ramanakoppa H. Nagaraj,Satoshi Miyata	62
17	Pentosidine: A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia 1991 ·Diabetes/Metabolism Reviews ·David R. Sell,Ramanakoppa H. Nagaraj,(unknown),Patrizio Odetti,Annunziata Lapolla,John Fogarty,Vincent M. Monnier	145
18	End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. 1990 ·Journal of Clinical Investigation ·David R. Sell,Vincent M. Monnier	239
19	Mucin excretion and morphology of the intestinal tract as influenced by sorghum tannins 1985 ·Nutrition reports international ·David R. Sell,(unknown),Cheryl L. Chrisman,J.C. Rogler	39
20	Effects of stage of maturity on the tannin content and nutritional quality of low and high tannin sorghum 1984 ·Nutrition reports international ·J.C. Rogler,David R. Sell	4

About David R. Sell

David R. Sell is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Aging, having authored 81 papers that have together received 6.4k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (56 papers), Biochemical effects in animals (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). The work is most often cited by research in Clinical Biochemistry (3.9k citations), Endocrinology, Diabetes and Metabolism (2.1k citations) and Aging (122 citations). David R. Sell has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Vincent M. Monnier, Saul Genuth, Patrizio Odetti, Patricia A. Cleary, John Fogarty, Christopher Strauch, William T. Dahms, Ramanakoppa H. Nagaraj, Wanjie Sun and John M. Lachin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact